These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20196643)

  • 1. Physicochemical characterization of gliclazide-macrogol solid dispersion and tablets based on optimized dispersion.
    Khattab IS; Nada A; Zaghloul AA
    Drug Dev Ind Pharm; 2010 Aug; 36(8):893-902. PubMed ID: 20196643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000.
    Biswal S; Sahoo J; Murthy PN; Giradkar RP; Avari JG
    AAPS PharmSciTech; 2008; 9(2):563-70. PubMed ID: 18459056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.
    Hussain T; Saeed T; Mumtaz AM; Javaid Z; Abbas K; Awais A; Idrees HA
    Acta Pol Pharm; 2013; 70(4):749-57. PubMed ID: 23923399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
    Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
    Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes.
    Tiwari R; Gupta A; Joshi M; Tiwari G
    PDA J Pharm Sci Technol; 2014; 68(2):138-52. PubMed ID: 24668601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
    El-Maghraby GM; Alomrani AH
    Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
    Meka VS; Yee P; Sheshala R
    Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of solid dispersion systems in hydrophilic carriers to increase benzonidazole solubility.
    Lima AA; Soares-Sobrinho JL; Silva JL; Corrêa-Júnior RA; Lyra MA; Santos FL; Oliveira BG; Hernandes MZ; Rolim LA; Rolim-Neto PJ
    J Pharm Sci; 2011 Jun; 100(6):2443-51. PubMed ID: 21491453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
    SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
    Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2012 Jul; 9(4):395-404. PubMed ID: 22640037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, Characterization and In-vitro Evaluation of Fast Dissolv ing Tablets Containing Gliclazide Hydrotropic Solid Dispersions.
    Madan JR; Kamate VJ; Awasthi R; Dua K
    Recent Pat Drug Deliv Formul; 2017; 11(2):147-154. PubMed ID: 28460615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.